Lennham Pharmaceuticals
Concord, US · Founded 2019 · Delaware corporation
Lennham applies deuterium chemistry to modify the metabolic and pharmacokinetic properties of drug compounds, aiming to develop pharmaceutical products with improved profiles and patent protection. The company identifies compounds that could benefit from such modification and advances candidates with clinical and commercial potential.
Founders & leadership
BD
Benjamin D. EnersonExecutive
CM
Corey MacGregorExecutive
BC
Bradford C. SippyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 2 rounds · 2019–2021
▶$1.2MraisedApr 2023 · 13 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedApr 2023 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin D. EnersonExecutive Officer
- Bradford C. SippyExecutive Officer, Director
- Corey MacGregorExecutive Officer
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $50K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.3MraisedMar 2021 · 19 investors · PharmaceuticalsRule 506(b)
▶$2.3MraisedMar 2021 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Corey MacGregorExecutive Officer
- Benjamin D. EnersonExecutive Officer
- Bradford C. SippyExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- Minimum investment
- $50K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Medscape6 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Oup3 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Companies competing with Lennham Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Lennham Pharmaceuticals do?
- Lennham applies deuterium chemistry to modify the metabolic and pharmacokinetic properties of drug compounds, aiming to develop pharmaceutical products with improved profiles and patent protection. The company identifies compounds that could benefit from such modification and advances candidates with clinical and commercial potential.
- How much funding has Lennham Pharmaceuticals raised?
- Lennham Pharmaceuticals has disclosed $3.5M raised across 2 rounds.
- Where is Lennham Pharmaceuticals headquartered?
- Lennham Pharmaceuticals is headquartered in Concord, US.